Eco Animal Health (GB:EAH) has released an update.
ECO Animal Health Group PLC, a prominent player in the animal pharmaceuticals market, has announced that their CEO, David Hallas, has acquired 18,181 shares at 110 pence per share, thereby raising his total stake in the company to 0.16%. The company is known for its lead product Aivlosin®, which treats respiratory and intestinal diseases in pigs and poultry, and operates globally with over 200 employees.
For further insights into GB:EAH stock, check out TipRanks’ Stock Analysis page.
